BenzingaAugust 11, 2026 at 3:22 AM NY24 days ago

Aura Biosciences Q2 EPS $(0.48) Misses $(0.38) Estimate

Aura Biosciences (NASDAQ:AURA) reported quarterly losses of $(0.48) per share which missed the analyst consensus estimate of $(0.38) by 29.73 percent. This is a 2.13 percent decrease over losses of $(0.47) per share

Read the Full Story at the Source

The summary here comes from the news provider; the rest of the article lives on the publisher's site — Benzinga

Read at Source

Companies in This Story

AURAAura Biosciences Inc7.56+ 2.58%

Companies in This Story

Related Stories